Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro

Clinical Immunology

Volumn 131, Issue 1, 2009, Pages 92-97

  Zhu, Chengliang ^a   Zhang, Rui ^a   Liu, Li ^a   Rasool, Sahibzada T ^a   Mu, Yongxin ^a   Sun, Wei ^a   Hao, Qian ^a   Liu, Fang ^a   Zhu, Ying ^a   Wu, Jianguo ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Acute hepatitis B; Chronic hepatitis B; Cytokines; HBV e antigen; Hepatitis B virus; Hepatocellular carcinoma; Interleukin 27; Liver cirrhosis

Indexed keywords

HEPATITIS E ANTIGEN; INTERLEUKIN 27;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ACUTE DISEASE; ADULT; ANTIGEN PRESENTATION; CELL LINE; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; MONOCYTES; TRANSFECTION; VIRAL LOAD;

EID: 63249115116     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.10.011     Document Type: Article

References (34)

1. Arthur M.J., Hall A.J., and Wright R. Hepatitis B, hepatocellular carcinoma, and strategies for prevention. Lancet 1 (1984) 607-610
2. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61 (1988) 1942-1956
3. Blumberg B.S., and London W.T. Hepatitis B virus and the prevention of primary hepatocellular carcinoma. N. Engl. J. Med. 304 (1981) 782-784
4. Huang C.F., Lin S.S., Ho Y.C., Chen F.L., and Yang C.C. The immune response induced by hepatitis B virus principal antigens. Cell. Mol. Immunol. 3 (2006) 97-106
5. Hui C.K., and Lau G.K. Immune system and hepatitis B virus infection. J. Clin. Virol. 34 Suppl. 1 (2005) S44-48
6. Bertoletti A., and Maini M.K. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?. Curr. Opin. Microbiol. 3 (2000) 387-392
7. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., Hibbert L., Churakova T., Travis M., Vaisberg E., Blumenschein W.M., Mattson J.D., Wagner J.L., To W., Zurawski S., McClanahan T.K., Gorman D.M., Bazan J.F., de Waal Malefyt R., Rennick D., and Kastelein R.A. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16 (2002) 779-790
8. Pflanz S., Hibbert L., Mattson J., Rosales R., Vaisberg E., Bazan J.F., Phillips J.H., McClanahan T.K., and de Waal Malefyt R. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172 (2004) 2225-2231
9. Batten M., and Ghilardi N. The biology and therapeutic potential of interleukin 27. J. Mol. Med. 85 (2007) 661-672
10. Kastelein R.A., Hunter C.A., and Cua D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25 (2007) 221-242
11. Wirtz S., Becker C., Fantini M.C., Nieuwenhuis E.E., Tubbe I., Galle P.R., Schild H.J., Birkenbach M., Blumberg R.S., and Neurath M.F. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. J. Immunol. 174 (2005) 2814-2824
12. Langrish C.L., McKenzie B.S., Wilson N.J., de Waal Malefyt R., Kastelein R.A., and Cua D.J. IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 202 (2004) 96-105
13. Rosas L.E., Satoskar A.A., Roth K.M., Keiser T.L., Barbi J., Hunter C., de Sauvage F.J., and Satoskar A.R. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology. Am. J. Pathol. 168 (2006) 158-169
14. Fakruddin J.M., Lempicki R.A., Gorelick R.J., Yang J., Adelsberger J.W., Garcia-Pineres A.J., Pinto L.A., Lane H.C., and Imamichi T. Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27. Blood 109 (2007) 1841-1849
15. Matsui M., Moriya O., Belladonna M.L., Kamiya S., Lemonnier F.A., Yoshimoto T., and Akatsuka T. Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. J. Virol. 78 (2004) 9093-9104
16. Song le H., Binh V.Q., Duy D.N., Kun J.F., Bock T.C., Kremsner P.G., and Luty A.J. Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. J. Clin. Virol. 28 (2003) 93-103
17. Bozkaya H., Bozdayi M., Turkyilmaz R., Sarioglu M., Cetinkaya H., Cinar K., Kose K., Yurdaydin C., and Uzunalimoglu O. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease. Hepatogastroenterology 47 (2000) 1675-1679
18. Tulek N., Saglam S.K., Saglam M., Turkyilmaz R., and Yildiz M. Soluble interleukin-2 receptor and interleukin-10 levels in patients with chronic hepatitis B infection. Hepatogastroenterology 47 (2000) 828-831
19. Song le H., Binh V.Q., Duy D.N., Juliger S., Bock T.C., Luty A.J., Kremsner P.G., and Kun J.F. Mannose-binding lectin gene polymorphisms and hepatitis B virus infection in Vietnamese patients. Mutat. Res. 522 (2003) 119-125
20. Dangond F., Hafler D.A., Tong J.K., Randall J., Kojima R., Utku N., and Gullans S.R. Differential display cloning of a novel human histone deacetylase (HDAC3) cDNA from PHA-activated immune cells. Biochem. Biophys. Res. Commun. 242 (1998) 648-652
21. Taga T., and Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15 (1997) 797-819
22. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3 (2003) 133-146
23. Trinchieri G., Pflanz S., and Kastelein R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19 (2003) 641-644
24. Cavanaugh V.J., Guidotti L.G., and Chisari F.V. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J. Virol. 71 (1997) 3236-3243
25. Lucas S., Ghilardi N., Li J., and de Sauvage F.J. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 15047-15052
26. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T.W., Yoshimura A., and Yoshida H. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170 (2003) 4886-4890
27. Chiyo M., Shimozato O., Yu L., Kawamura K., Iizasa T., Fujisawa T., and Tagawa M. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int. J. Cancer 115 (2005) 437-442
28. Hisada M., Kamiya S., Fujita K., Belladonna M.L., Aoki T., Koyanagi Y., Mizuguchi J., and Yoshimoto T. Potent antitumor activity of interleukin-27. Cancer Res. 64 (2004) 1152-1156
29. Salcedo R., Stauffer J.K., Lincoln E., Back T.C., Hixon J.A., Hahn C., Shafer-Weaver K., Malyguine A., Kastelein R., and Wigginton J.M. IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells. J. Immunol. 173 (2004) 7170-7182
30. Lee Y., Park U.S., Choi I., Yoon S.K., Park Y.M., and Lee Y.I. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells. Clin. Cancer Res. 4 (1998) 1711-1717
31. Deviere J., Content J., Denys C., Vandenbussche P., Schandene L., Wybran J., and Dupont E. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Clin. Exp. Immunol. 77 (1989) 221-225
32. Imamichi T., Yang J., Huang D.W., Brann T.W., Fullmer B.A., Adelsberger J.W., Lempicki R.A., Baseler M.W., and Lane H.C. IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages. AIDS 22 (2008) 39-45
33. Hibbert L., Pflanz S., De Waal Malefyt R., and Kastelein R.A. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J. Interferon Cytokine Res. 23 (2003) 513-522
34. Larousserie F., Pflanz S., Coulomb-L'Hermine A., Brousse N., Kastelein R., and Devergne O. Expression of IL-27 in human Th1-associated granulomatous diseases. J. Pathol. 202 (2004) 164-171